Lesson plan

Fowler's solution

Fowler's solution consists of 1% potassium arsenite (KAsO 2 ) in water and was first described and published as a potential treatment for malaria and syphilis in the late 1700s and was once also prescribed as a tonic. Thomas Fowler (1736–1801) of Stafford, England, proposed the solution in 1786 as a substitute for a patent medicine, "tasteless ague drop". It was known at the time as "Liquor Arsenicalis". From 1865, Fowler's solution was a leukemia treatment. From 1905, inorganic arsenicals like Fowler's solution saw diminished use as attention turned to organic arsenicals, starting with Atoxyl. As inorganic arsenic compounds are notably toxic and carcinogenic—with side effects such as cirrhosis of the liver, idiopathic portal hypertension, urinary bladder cancer, and skin cancers—Fowler's solution fell from use. In 2001, however, the U.S. Food and Drug Administration (FDA) approved a drug of arsenic trioxide to treat acute promyelocytic leukaemia, and interest in arsenic chemistry has returned.

Back to article

Article summary

Fowler's solution consists of 1% potassium arsenite (KAsO 2 ) in water and was first described and published as a potential treatment for malaria and syphilis in the late 1700s and was once also prescribed as a tonic. Thomas Fowler (1736–1801) of Stafford, England, proposed the solution in 1786 as a substitute for a patent medicine, "tasteless ague drop". It was known at the time as "Liquor Arsenicalis". From 1865, Fowler's solution was a leukemia treatment. From 1905, inorganic arsenicals like Fowler's solution saw diminished use as attention turned to organic arsenicals, starting with Atoxyl. As inorganic arsenic compounds are notably toxic and carcinogenic—with side effects such as cirrhosis of the liver, idiopathic portal hypertension, urinary bladder cancer, and skin cancers—Fowler's solution fell from use. In 2001, however, the U.S. Food and Drug Administration (FDA) approved a drug of arsenic trioxide to treat acute promyelocytic leukaemia, and interest in arsenic chemistry has returned.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.